Market Place
Sourcing Support
Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)
12 Oct 2021 //
PROFESSIONALS
Enforcement Report - Week of January 13, 2021
13 Jan 2021 //
FDA
Enforcement Report - Week of January 6, 2021
06 Jan 2021 //
FDA
Health Canada Issues Recall Merck Canada Inc`s Zerbaxa
18 Dec 2020 //
HEALTH CANADA
Ceftolozane/tazobactam: New treatment option for severe infections
02 Jul 2020 //
MEDICALXPRESS
EMA committee recommends approval of Merck`s Zerbaxa 3g dose
31 Jul 2019 //
PHARMABIZ
Merck`s treatment for urinary, abdominal infections gets FDA approval
17 Jul 2019 //
REUTERS
Merck`s new combo med Recarbrio fights resistant bacteria
17 Jul 2019 //
FIERCE PHARMA
Merck scores a new Zerbaxa indication
05 Jun 2019 //
FIERCE PHARMA
Results of Ph3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam)
15 Apr 2019 //
BUSINESSWIRE
FDA accepts two of MSD’s new drug applications
06 Feb 2019 //
PHARMA TIMES
Merck set to seek EU, US approval of Zerbaxa for pneumonia
12 Sep 2018 //
FIRST WORD PHARMA
Merck heralds a rare Big Pharma success for antibiotic PhIII, but..
11 Sep 2018 //
ENDPTS
Merck finally adds postsurgery med Bridion to US lineup.Will buyer step up?
16 Dec 2015 //
FIERCE PHARMA MARKETING
MSD debuts new antibiotic in the UK
22 Nov 2015 //
PHARMA TIMES
What Does Merck`s $10B Buyback Plan Say About Pharma M&A?
27 Mar 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.